Back to Trades
Sell4
RECURSION PHARMACEUTICALS, INC.
RXRX
Total Value
$223.5K
Sales
$202.2K
1 transaction
Company Information
- Company Name
- RECURSION PHARMACEUTICALS, INC.
- Ticker Symbol
- RXRX
- CIK
- 0001601830
Insider Information
- Name
- Khan Najat
- Role
- Chief R&D Commercial Officer, Director
- Location
- SALT LAKE CITY, UT
Filing Details
- Filing Date
- Aug 19, 2025
- Transaction Date
- Aug 15, 2025
- Accession Number
- 0001601830-25-000131
- Form Type
- 4